Research Article
Prevalence of Anxiety and Depression in Prostate Cancer Patients and Their Spouses: An Unaddressed Reality
Table 1
General characteristics of the population.
| | Mean/median | Range/SD |
| Age | Patients () | 70.71/71 | 49–92/8.3 | Spouses () | 68.3/68 | 45–87/7.9 |
| Time since diagnosis (months): | 33.3/18 | 2–142/34.27 |
| PSA (ng/ml) | 2.88/0.1 | 0–88/12.18 |
| VAS | 0.42/0 | 0–2/0.54 | VAS 0: (60.9%) | VAS 1: (36.4%) | VAS 2: (2.7%) |
| Patient education level | Spouse education level | Elementary: (53.8%) | Elementary: (64.2%) | High school: (37%) | High school (27%) | University: (9.2%) | University: (8.8%) |
| Comorbidities: | None: 40 (21.7%) | Cormob 1: 58 (31.5%) | Comorb 2: 64 (34.9%) | Mean: 1.36 | Comorb 3 or more: 22 (11.9%) | Median: 1 |
| Stage () | Localized (63.7%) | L. advanced (17.9%) | MTX (13%) | CRPC (5.4%) |
| Primary treatment () | Time since diagnosis (months): | AS (; 10.9%) | 33.29 (median: 18), range: 2–142 | RP (: 53.8%) | 55.9 (median: 48), range: 11–132 | RT (: 8.7%) | 30.5 (median: 18), range: 2–142 | HT (: 26.6%) | 12.8 (median: 12), range: 2–28 | ST: (22.3%) | 39.8 (median: 23), range: 3–138 |
|
|
MTX: metastatic; CRPC: Castrate-resistant prostate cancer. AS: active surveillance; RP: radical prostatectomy; RT: radiotherapy; HT: hormone therapy; ST: sequential treatment. |